Opinion

Video

Patient Monitoring Strategies in BCG-Unresponsive NMIBC

Author(s):

Gordon A. Brown, DO,Siamak Daneshmand, MD

Bladder cancer specialists discuss their strategies for monitoring patients with BCG-unresponsive non–muscle invasive bladder cancer.

Current Time 0:00
Duration 4:18
Loaded: 3.81%
Stream Type LIVE
Remaining Time 4:18
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Related Videos
    Vignesh Packiam, MD, on choosing between options in NMIBC
    Vignesh Packiam, MD, on choosing between options in NMIBC
    Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
    Strategies to bridge gender disparities in AAS and citations in the oncology literature
    4 experts in this video
    Case 3: A 49-Year-Old Man With Recurrent Non–Muscle-Invasive Bladder Cancer
    4 experts in this video
    Case 2: A 68-Year-Old Woman With Non–Muscle-Invasive Bladder Cancer
    Female doctor typing on her laptop computer in medical office | Image Credit: © Rostislav Sedlacek - stock.adobe.com
    Study findings highlight gender gaps in oncology authorship and citation
    4 experts in this video
    Case 1: A 79-Year-Old Man With Non–Muscle-Invasive Bladder Cancer
    4 experts in this video
    Non–Muscle Invasive-Bladder Cancer Overview
    Laura Davis, MD, on link between microplastics and bladder cancer
    Laura Davis, MD, on link between microplastics and bladder cancer
    Rebecca A. Campbell, MD, answers a question during a Zoom video interview
    Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
    Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
    Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
    Related Content
    From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
    June 16th 2025

    From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance

    Anne K. Schuckman, MD Hannah Clarke
    Anne K. Schuckman, MD, describes the growing number of options in NMIBC and the impact of these therapies on clinical practice.
    medical depiction of bladder cancer
    May 31st 2023

    Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

    Urology Times staff
    In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
    FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
    June 12th 2025

    FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC

    Hannah Clarke
    The approval is supported by findings from the phase 3 ENVISION trial.
    Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
    May 26th 2022

    Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease

    Urology Times staff
    “We know that erectile dysfunction is really an important issue that can be a harbinger for other underlying cardiovascular or neurological health issues,” says Michael Lutz, MD.
    Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
    June 9th 2025

    En bloc resection of bladder tumor: Is it the way forward?

    Jeremy Teoh, MBBS, FRCSEd (Urol), FCSHK, FHKAM (Surgery)
    "As urologists, we are the gatekeepers, and we must always perform the best possible surgery to optimize oncological outcomes," writes Jeremy Teoh, MBBS, FRCSEd (Urol), FCSHK, FHKAM (Surgery).
    Survey: New NMIBC treatments face slow uptake
    June 2nd 2025

    Survey: New NMIBC treatments face slow uptake

    Benjamin P. Saylor
    Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
    © 2025 MJH Life Sciences

    All rights reserved.